TY - CONF T1 - Adjusting for treatment crossover in the METRIC metastatic melanoma (MM) trial for trametinib: Preliminary analysis JO - JOURNAL OF CLINICAL ONCOLOGY PY - 2013/05/20 AU - Abrams KR AU - Latimer N AU - Amonkar M AU - Stapelkamp C AU - Casey M AU - Grp T ED - VL - 31 IS - 15 Y2 - 2025/04/06 ER -